SLAS 2013
12 January 2013 - 16 January 2013
Why should you take part in SLAS2013 – the 2nd Annual SLAS Conference and Exhibition? Because it’s where 4,500 of the best global laboratory science and technology minds -- innovative scientists, engineers, researchers and technologists from academic, government and commercial laboratories -- come together to learn, explore and gain repeatable inspiration from leaders in the field. In addition to significant networking opportunities, you will have access to 130 outstanding podium presentations comprising 30 unique scientific sessions, over 300 posters and new and emerging technologies from 300+ exhibitors from around the world. SLAS2013 will inspire your scientific creativity long after you leave Orlando, Florida.
To learn more, visit slas2013.org.
Orlando, Florida, USA
http://www.slas2013.org/
3rd Annual Pharma R&D World Asia Congress 2013
17 January 2013 - 18 January 2013
The 3rd annual Pharma R&D World Asia Congress will be held in Shanghai, China on the 17th & 18th January 2013. Over two days, will attract over 150 senior-level decision makers working in R&D, Translational Sciences, Discovery and Development, External Research and Business Development from multinational and local pharma and biopharma companies and healthcare institutes from China, Singapore, Australia, Japan, Korea, Thailand, Malaysia. Prominent key leaders from Europe and US will also be represented.
InterContinental Shanghai Pudong, Shanghai, China
http://www.pharmaworldasia-congress.com/?utm_source=Etelligent&utm_medium=Email&utm_campaign=Media+partners+2013&utm_content=www%2Epharmaworldasia%2Dcongress%2Ecom
2nd Annual Clinical Trials & Outsourcing Congress 2013
17 January 2013 - 18 January 2013
The 2nd Annual Clinical Trials and Outsourcing Asia Congress will be held in Shanghai, China on the 17th & 18th January 2013. Over two days, the event will attract over 150 senior-level decision makers working in clinical development, clinical trials management, clinical operations and clinical outsourcing from multinational and local pharma and biopharma companies and healthcare institutes from China, Singapore, India, Australia, Japan, Korea, and other emerging markets. Prominent insights into how Chinese pharmaceutical companies reach beyond their local markets to other regions in Asia are also presented.
InterContinental Shanghai Pudong, Shanghai, China
http://www.clinicalasia-congress.com/?utm_source=Etelligent&utm_medium=Email&utm_campaign=Media+partners+2013&utm_content=www%2Eclinicalasia%2Dcongress%2Ecom
5th Annual Optimizing Biologics Formulation Development
21 January 2013 - 22 January 2013
This annual conference will cover the latest trends and challenges in biologics formulation with a focus on both the optimization of the formulation process and the biologic molecule itself for greater ‘formulatability’ and ‘developability’. It will feature in-depth case studies and interactive discussions on early formulation screening, thorough biophysical and analytical characterization, improving the feedback loop in the early formulation-development interface, use of experimental design and high-throughput principles, overcoming aggregation and other heterogeneity challenges, and improving overall product profile.
Palm Springs, CA, US
http://www.chi-peptalk.com/BiologicsFormulation/
Cell Based Assays (part of CellTech 2013)
22 January 2013 - 23 January 2013
There is constant demand to refine this powerful research tool. This conference will present the latest information regarding how to improve the accuracy of this technique - including optimising cellular conditions, developing quantitative technologies and enhancement of biomarkers. Speakers will focus on the ways in which this technique facilitates research in numerous therapeutic areas, notably stem cells and oncology.
San Diego, USA
http://selectbiosciences.com/conferences/index.aspx?conf=CBA2013
Quality by Design
23 January 2013 - 24 January 2013
Achieving Quality by Design requires products and processes meeting predefined levels of quality, safety and efficacy. Covering QbD as an end-to-end process for pharmaceuticals and biotherapeutics, attending this innovative, two-day conference will enable you to:
Refine and enhance a product's critical quality attributes Develop a better manufacturing process design space Employ QbD to design a formulation process Harness raw material analysis and control strategy Utilise PAT tools and applications for pharmaceuticals, biopharmaceuticals and ATMPs Use risk assessment and management to best effect Accurately include QbD information in regulatory document filings, including those for ICH Q8 and ASTM E 2500 Apply multivariate data analysis to maximise product development and patient outcomes Decrease development risks and overall costs Improve product value, maturity and performance Streamline R&D and pre-market reviews Increase regulatory compliance and flexibility Meet patient needs and maximise performance requirements
Copthorne Tara Hotel, London, UK
http://www.smi-online.co.uk/pharmaceuticals/uk/quality-by-design?utm_source=P-079&utm_medium=EM%20-%20PM&utm_campaign=GroupMail
8th Annual International Conference on Predictive Human Toxicity and ADME/Tox Studies
24 January 2013 - 25 January 2013
The desire to bring new drugs to market faster is a key driver of pharmaceutical companies. Being able to identify drug candidates faster with fewer missed hits has streamlined the screening process, but having insufficient knowledge of potential human toxicity early on can turn a successful drug into a devastating loss.
Mondial Research has joined with strategic partners from the Biotech and Pharmaceutical Industry to bring together scientific experts to present and discuss recent advances towards accurately predicting human toxicities and screening earlier in the drug discovery process.
Brussels, Belgium
http://www.mondialresearchgroup.com/index.php?whereTo=humt13
2nd Allergy Drug Discovery
31 January 2013 - 01 February 2012
The conference will bring together industry, academia and government experts in the field of allergy, asthma and COPD. Experts will facilitate discourse on the challenges and opportunities for therapeutic and drug development for allergic diseases for the current and future generations. Topics will range from basic scientific research to biomarkers and clinical development. Novel immune targets, new therapeutic interventions, genetics, epigenetics and biomarkers in allergic diseases will be presented
The Westin Gaslamp Quarter San Diego, 910 Broadway Circle, San Diego, CA 92101
http://www.gtcbio.com/index.php?option=com_conference&file=home&cn=2nd%20Allergy%20Drug%20Discovery&cid=53
Immunogenicity & Immunotoxicity
31 January 2013 - 01 February 2013
This is the West Coast's first 2 day conference that brings together leading experts in industry, academia and the FDA. The inaugural conference will provide in-depth analysis, panel discussions and speaker presentations on cutting edge research and technologies in an intimate atmosphere. In addition the conference will focus on a number of topics including Immunogenicity Prediction, Risk, Mitigation and Clinical Relevance. With Southern California home to a number of industry leaders in the field, this event promises to become a must attend conference.
The Westin Gaslamp Quarter San Diego, 910 Broadway Circle, San Diego, CA 92101
http://www.gtcbio.com/index.php?option=com_conference&file=home&cn=Immunogenicity%20&cid=109
5th Immunotherapeutics & Immunomonitoring Conference
31 January 2013 - 01 February 2013
Network with clinical immunologists, pathologists, and pharmacologists, as well as practicing clinicians and R&D scientists, to discuss the newest development in the field. Leading experts from the scientific and clinical arenas and industry will present about novel findings and developments in the constantly changing area of immunological assays and procedures. They will also discuss recent advances in immunotherapy, as they relate to various immunotherapy modalities, specific cancers, cell subsets, animal models, and tumor microenvironment. Potential clinical feasibility and commercial potential of the newest data obtained from leading biomedical research laboratories will also be discussed
The Westin Gaslamp Quarter San Diego, 910 Broadway Circle, San Diego, CA 92101
http://www.gtcbio.com/component/conference/?file=home&cn=5th+ImmunoTherapeutics+&ImmunoMonitoring=&cid=52
ELRIG Research and Innovation
19 March 2013
Cellular Toxicology in Drug Discovery
Innovation in Cell Culture
Tags & Binders
The objective is to provide a communication, education and networking opportunity for scientists engaged in early-phase drug discovery whether in academia, biotech or industry. The 3 sessions will attract world class speakers discussing challenges and opportunities in developing new technologies.
The scientific sessions have been chosen as they represent major areas of research important to all areas of drug discovery. The scientific sessions will be complemented by a poster session, a vendor exhibition with over 35 exhibitors, including an Innovation Zone where fledgling companies will showcase their new technologies.
Telford International Centre, UK
http://www.elrig.org/
BioScotland 2013
30 April 2013
BioScotland 2013 is being organised by The Allancia Group in conjunction with the University of Strathclyde, as part of the University of Strathclyde’s ‘Engage with Strathclyde’ week of events
The event will seek to provide a platform for delegates to meet like minded people and discuss ideas and exchanges possible solutions while building strong collaborations and business connections for the future.
The Barony Hall, The University of Strathclyde, Glasgow, Scotland
http://www.bioscotland.co.uk/
Paediatric Drug Development
08 July 2013
This uniquely interactive full day masterclass will present attendees with an indepth overview into the practical aspects of pediatric
drug development alongside efficient and effective methods to overcome challenges faced. The event, led by the expertise and experience of Dr. Klaus Rose, Managing Director, klausrose Consulting, will provide a focus on: pediatric clinical trials, legislation considerations, Pediatric Investigation Plan (PIP) and the impact of the pediatric legislation in both US and EU. The event will also act as an ideal platform for problem solving, debate and discussion into key obstacles facing the pediatric drug development process.
Holiday Inn London-Bloomsbury , London, UK
http://www.smi-online.co.uk/pharmaceuticals/uk/masterclass/pediatric-drug-development?utm_source=MC306&utm_medium=EM%20-%204S&utm_campaign=GroupMail
Can Medicine Be Your Food?The challenging borderline between herbal medicines and botanicals
28 October 2013
A symposium exploring the borderline between herbal medicines and food supplements to be held at the Royal Botanic Gardens, Kew, London
Jodrell Laboratory, Royal Botanic Gardens, Kew, London, UK
http://bhma.info/index.php/registration/